HEADER    PEPTIDE BINDING PROTEIN                 14-OCT-20   7AOL              
TITLE     STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO CLIMBAZOLE             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: 3C-LIKE PROTEINASE;                                        
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5,   
COMPND   5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE;                               
COMPND   6 EC: 3.4.22.69;                                                       
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS   
SOURCE   3 2;                                                                   
SOURCE   4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2;                              
SOURCE   5 ORGANISM_TAXID: 2697049;                                             
SOURCE   6 GENE: REP, 1A-1B;                                                    
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    SARS-COV-2, MPRO, COVID-!9, PEPTIDE BINDING PROTEIN                   
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    S.GUENTHER,P.REINKE,D.OBERTHUER,O.YEFANOV,L.GELISIO,H.GINN,J.LIESKE,  
AUTHOR   2 M.DOMARACKY,W.BREHM,A.RAHMANI MASHOUR,T.A.WHITE,J.KNOSKA,G.PENA      
AUTHOR   3 ESPERANZA,F.KOUA,A.TOLSTIKOVA,M.GROESSLER,P.FISCHER,V.HENNICKE,      
AUTHOR   4 H.FLECKENSTEIN,F.TROST,M.GALCHENKOVA,Y.GEVORKOV,C.LI,S.AWEL,         
AUTHOR   5 L.X.PAULRAJ,N.ULLAH,S.FALKE,B.ALVES FRANCA,M.SCHWINZER,H.BROGNARO,   
AUTHOR   6 N.WERNER,M.PERBANDT,H.TIDOW,B.SEYCHELL,T.BECK,S.MEIER,J.J.DOYLE,     
AUTHOR   7 H.GISELER,D.MELO,I.DUNKEL,T.J.LANE,A.PECK,S.SAOUANE,J.HAKANPAEAE,    
AUTHOR   8 J.MEYER,H.NOEI,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,L.ZHANG,C.EHRT, 
AUTHOR   9 J.PLETZER-ZELGERT,J.WOLLENHAUPT,C.FEILER,M.WEISS,E.C.SCHULZ,         
AUTHOR  10 P.MEHRABI,B.NORTON-BAKER,C.SCHMIDT,K.LORENZEN,R.SCHUBERT,H.HAN,      
AUTHOR  11 A.CHARI,Y.FERNANDEZ GARCIA,D.TURK,R.HILGENFELD,M.RAREY,A.ZALIANI,    
AUTHOR  12 H.N.CHAPMAN,A.PEARSON,C.BETZEL,A.MEENTS                              
REVDAT   4   19-MAY-21 7AOL    1       JRNL                                     
REVDAT   3   14-APR-21 7AOL    1       COMPND SOURCE JRNL   DBREF               
REVDAT   3 2                   1       SEQADV                                   
REVDAT   2   09-DEC-20 7AOL    1       JRNL   REMARK                            
REVDAT   1   02-DEC-20 7AOL    0                                                
JRNL        AUTH   S.GUNTHER,P.Y.A.REINKE,Y.FERNANDEZ-GARCIA,J.LIESKE,T.J.LANE, 
JRNL        AUTH 2 H.M.GINN,F.H.M.KOUA,C.EHRT,W.EWERT,D.OBERTHUER,O.YEFANOV,    
JRNL        AUTH 3 S.MEIER,K.LORENZEN,B.KRICHEL,J.D.KOPICKI,L.GELISIO,W.BREHM,  
JRNL        AUTH 4 I.DUNKEL,B.SEYCHELL,H.GIESELER,B.NORTON-BAKER,               
JRNL        AUTH 5 B.ESCUDERO-PEREZ,M.DOMARACKY,S.SAOUANE,A.TOLSTIKOVA,         
JRNL        AUTH 6 T.A.WHITE,A.HANLE,M.GROESSLER,H.FLECKENSTEIN,F.TROST,        
JRNL        AUTH 7 M.GALCHENKOVA,Y.GEVORKOV,C.LI,S.AWEL,A.PECK,M.BARTHELMESS,   
JRNL        AUTH 8 F.SCHLUNZEN,P.LOURDU XAVIER,N.WERNER,H.ANDALEEB,N.ULLAH,     
JRNL        AUTH 9 S.FALKE,V.SRINIVASAN,B.A.FRANCA,M.SCHWINZER,H.BROGNARO,      
JRNL        AUTH10 C.ROGERS,D.MELO,J.J.ZAITSEVA-DOYLE,J.KNOSKA,                 
JRNL        AUTH11 G.E.PENA-MURILLO,A.R.MASHHOUR,V.HENNICKE,P.FISCHER,          
JRNL        AUTH12 J.HAKANPAA,J.MEYER,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,    
JRNL        AUTH13 A.R.BECCARI,G.BOURENKOV,D.VON STETTEN,G.POMPIDOR,I.BENTO,    
JRNL        AUTH14 S.PANNEERSELVAM,I.KARPICS,T.R.SCHNEIDER,M.M.GARCIA-ALAI,     
JRNL        AUTH15 S.NIEBLING,C.GUNTHER,C.SCHMIDT,R.SCHUBERT,H.HAN,J.BOGER,     
JRNL        AUTH16 D.C.F.MONTEIRO,L.ZHANG,X.SUN,J.PLETZER-ZELGERT,              
JRNL        AUTH17 J.WOLLENHAUPT,C.G.FEILER,M.S.WEISS,E.C.SCHULZ,P.MEHRABI,     
JRNL        AUTH18 K.KARNICAR,A.USENIK,J.LOBODA,H.TIDOW,A.CHARI,R.HILGENFELD,   
JRNL        AUTH19 C.UETRECHT,R.COX,A.ZALIANI,T.BECK,M.RAREY,S.GUNTHER,D.TURK,  
JRNL        AUTH20 W.HINRICHS,H.N.CHAPMAN,A.R.PEARSON,C.BETZEL,A.MEENTS         
JRNL        TITL   X-RAY SCREENING IDENTIFIES ACTIVE SITE AND ALLOSTERIC        
JRNL        TITL 2 INHIBITORS OF SARS-COV-2 MAIN PROTEASE.                      
JRNL        REF    SCIENCE                       V. 372   642 2021              
JRNL        REFN                   ESSN 1095-9203                               
JRNL        PMID   33811162                                                     
JRNL        DOI    10.1126/SCIENCE.ABF7945                                      
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.GUENTHER,P.Y.A.,REINKE,Y.,FERNANDEZ-GARCIA,J.,LIESKE,T.J., 
REMARK   1  AUTH 2 LANE,H.M.,GINN,F.H.M.,KOUA,C.,EHRT,W.,EWERT,D.,OBERTHUER,O., 
REMARK   1  AUTH 3 YEFANOV,S.,MEIER,K.,LORENZEN,B.,KRICHEL,J.D.,KOPICKI,L.,     
REMARK   1  AUTH 4 GELISIO,W.,BREHM,I.,DUNKEL,B.,SEYCHELL,H.,GIESELER,B.,       
REMARK   1  AUTH 5 NORTON-BAKER,B.,ESCUDERO-PEREZ,M.,DOMARACKY,S.,SAOUANE,A.,   
REMARK   1  AUTH 6 TOLSTIKOVA,T.A.,WHITE,A.,HANLE,M.,GROESSLER,H.,FLECKENSTEIN, 
REMARK   1  AUTH 7 F.,TROST,M.,GALCHENKOVA,Y.,GEVORKOV,C.,LI,S.,AWEL,A.PECK,M., 
REMARK   1  AUTH 8 BARTHELMESS,F.,SCHLUENZEN,L.X.,PAULRAJ,N.,WERNER,H.,         
REMARK   1  AUTH 9 ANDALEEB,N.,ULLAH,S.,FALKE,V.,SRINIVASAN,B.,FRANCA,M.,       
REMARK   1  AUTH10 SCHWINZER,H.,BROGNARO,C.,ROGERS,D.,MELO,J.J.,DOYLE,J.,       
REMARK   1  AUTH11 KNOSKA,G.E.,PENA MURILLO,A.,RAHMANI MASHHOUR,F.,GUICKING,V., 
REMARK   1  AUTH12 HENNICKE,P.,FISCHER,J.,HAKANPAEAE,J.,MEYER,P.,GRIBBON,B.,    
REMARK   1  AUTH13 ELLINGER,M.,KUZIKOV,M.,WOLF,G.,BURENKOV,D.,VON STETTEN,G.,   
REMARK   1  AUTH14 POMPIDOR,I.,BENTO,S.,PANNEERSELVAM,I.,KARPICS,T.R.,          
REMARK   1  AUTH15 SCHNEIDER,M.,GARCIA ALAI,S.,NIEBLING,C.,GUENTHER,C.,SCHMIDT, 
REMARK   1  AUTH16 R.,SCHUBERT,H.,HAN,J.,BOGER,D.,MONTEIRO,L.,ZHANG,X.,SUN,J.,  
REMARK   1  AUTH17 PLETZER-ZELGERT,J.,WOLLENHAUPT,C.,FEILER,M.,WEISS,E.C.,      
REMARK   1  AUTH18 SCHULZ,P.,MEHRABI,K.,KARNICAR,A.,USENIK,J.,LOBODA,H.,TIDOW,  
REMARK   1  AUTH19 A.,CHARI,R.,HILGENFELD,C.,UETRECHT,R.,COX,A.,ZALIANI,T.,     
REMARK   1  AUTH20 BECK,M.,RAREY,S.,GUENTHER,D.,TURK,W.,HINRICHS,H.N.,CHAPMAN,  
REMARK   1  AUTH21 A.,PEARSON,C.,BETZEL,A.MEENTS                                
REMARK   1  TITL   INHIBITION OF SARS-COV-2 MAIN PROTEASE BY ALLOSTERIC         
REMARK   1  TITL 2 DRUG-BINDING                                                 
REMARK   1  REF    BIORXIV                                    2020              
REMARK   1  REFN                                                                
REMARK   1  DOI    10.1101/2020.11.12.378422                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.47 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : PHENIX 1.17.1_3660                                   
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN            
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,           
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,            
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,              
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,               
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,           
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT                  
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART                  
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2           
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 27.43                          
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 1.350                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.7                           
REMARK   3   NUMBER OF REFLECTIONS             : 43424                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.166                           
REMARK   3   R VALUE            (WORKING SET) : 0.165                           
REMARK   3   FREE R VALUE                     : 0.192                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 3.390                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 1470                            
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).                           
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE        
REMARK   3     1 27.4300 -  3.1700    0.99     4282   150  0.1274 0.1451        
REMARK   3     2  3.1700 -  2.5100    1.00     4215   148  0.1601 0.2155        
REMARK   3     3  2.5100 -  2.2000    1.00     4187   147  0.1672 0.1875        
REMARK   3     4  2.2000 -  1.9900    1.00     4207   147  0.1665 0.2073        
REMARK   3     5  1.9900 -  1.8500    1.00     4177   147  0.1863 0.1864        
REMARK   3     6  1.8500 -  1.7400    1.00     4193   146  0.1966 0.2387        
REMARK   3     7  1.7400 -  1.6600    1.00     4163   147  0.2106 0.2344        
REMARK   3     8  1.6600 -  1.5800    1.00     4198   147  0.2392 0.2543        
REMARK   3     9  1.5800 -  1.5200    1.00     4165   145  0.2496 0.2391        
REMARK   3    10  1.5200 -  1.4700    1.00     4167   146  0.2737 0.2773        
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED        : FLAT BULK SOLVENT MODEL                       
REMARK   3   SOLVENT RADIUS     : 1.11                                          
REMARK   3   SHRINKAGE RADIUS   : 0.90                                          
REMARK   3   K_SOL              : NULL                                          
REMARK   3   B_SOL              : NULL                                          
REMARK   3                                                                      
REMARK   3  ERROR ESTIMATES.                                                    
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.145            
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.669           
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 17.78                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 25.49                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  TWINNING INFORMATION.                                               
REMARK   3   FRACTION: NULL                                                     
REMARK   3   OPERATOR: NULL                                                     
REMARK   3                                                                      
REMARK   3  DEVIATIONS FROM IDEAL VALUES.                                       
REMARK   3                 RMSD          COUNT                                  
REMARK   3   BOND      :  0.007           2558                                  
REMARK   3   ANGLE     :  0.938           3487                                  
REMARK   3   CHIRALITY :  0.079            385                                  
REMARK   3   PLANARITY :  0.007            458                                  
REMARK   3   DIHEDRAL  : 18.048            915                                  
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  NCS DETAILS                                                         
REMARK   3   NUMBER OF NCS GROUPS : NULL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 7AOL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-OCT-20.                  
REMARK 100 THE DEPOSITION ID IS D_1292111806.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 27-APR-20                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : PETRA III, DESY                    
REMARK 200  BEAMLINE                       : P11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.033                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : PIXEL                              
REMARK 200  DETECTOR MANUFACTURER          : DECTRIS PILATUS 6M-F               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS, DIALS                         
REMARK 200  DATA SCALING SOFTWARE          : XSCALE                             
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 43435                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.470                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 27.430                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.7                               
REMARK 200  DATA REDUNDANCY                : 3.700                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 14.6100                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.52                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.87810                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHENIX                                                
REMARK 200 STARTING MODEL: 6YNQ                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 35.71                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.91                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 1500 5% DMSO 0.1 M MIB PH 7.5,   
REMARK 280  VAPOR DIFFUSION, TEMPERATURE 291K                                   
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       56.25200            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       26.41450            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       56.25200            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       26.41450            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY.  THE REMARK MAY ALSO  PROVIDE INFORMATION ON             
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER  REPRESENTING THE KNOWN          
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE  OF THE               
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT  TRANSFORMATIONS         
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC  AND                         
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE USED: UCSF CHIMERA 1.16_b42360.                             
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000 -0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1 -0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -1.000000 -0.000125 -0.000000       -0.00335            
REMARK 350   BIOMT2   2 -0.000125  1.000000  0.000920        0.00000            
REMARK 350   BIOMT3   2 -0.000000  0.000920 -1.000000       -0.00536            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH A 747  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 763  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 858  LIES ON A SPECIAL POSITION.                          
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  33     -133.10     48.57                                   
REMARK 500    ASN A  51       67.17   -151.94                                   
REMARK 500    ASN A  84     -120.85     52.32                                   
REMARK 500    TYR A 154      -98.18     59.46                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A 884        DISTANCE =  5.93 ANGSTROMS                       
REMARK 525    HOH A 885        DISTANCE =  5.95 ANGSTROMS                       
REMARK 525    HOH A 886        DISTANCE =  6.03 ANGSTROMS                       
REMARK 525    HOH A 887        DISTANCE =  6.21 ANGSTROMS                       
REMARK 525    HOH A 888        DISTANCE =  6.33 ANGSTROMS                       
REMARK 525    HOH A 889        DISTANCE =  6.51 ANGSTROMS                       
REMARK 525    HOH A 890        DISTANCE =  6.57 ANGSTROMS                       
REMARK 525    HOH A 891        DISTANCE =  6.71 ANGSTROMS                       
REMARK 525    HOH A 892        DISTANCE =  7.33 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 401                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 402                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue RQH A 403                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 404                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC5                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 405                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC6                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 406                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC7                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 407                 
DBREF  7AOL A    1   306  UNP    P0DTD1   R1AB_SARS2    3264   3569             
SEQADV 7AOL LEU A   72  UNP  P0DTD1    ASN  3335 CONFLICT                       
SEQRES   1 A  306  SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL          
SEQRES   2 A  306  GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR          
SEQRES   3 A  306  LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO          
SEQRES   4 A  306  ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO          
SEQRES   5 A  306  ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN          
SEQRES   6 A  306  PHE LEU VAL GLN ALA GLY LEU VAL GLN LEU ARG VAL ILE          
SEQRES   7 A  306  GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL          
SEQRES   8 A  306  ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL          
SEQRES   9 A  306  ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS          
SEQRES  10 A  306  TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET          
SEQRES  11 A  306  ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY          
SEQRES  12 A  306  SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS          
SEQRES  13 A  306  VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR          
SEQRES  14 A  306  GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR          
SEQRES  15 A  306  GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY          
SEQRES  16 A  306  THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU          
SEQRES  17 A  306  TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN          
SEQRES  18 A  306  ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA          
SEQRES  19 A  306  MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL          
SEQRES  20 A  306  ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA          
SEQRES  21 A  306  VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN          
SEQRES  22 A  306  ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU          
SEQRES  23 A  306  LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN          
SEQRES  24 A  306  CYS SER GLY VAL THR PHE GLN                                  
HET    DMS  A 401      10                                                       
HET    IMD  A 402      10                                                       
HET    RQH  A 403      37                                                       
HET    DMS  A 404      10                                                       
HET    DMS  A 405      10                                                       
HET    DMS  A 406      10                                                       
HET    DMS  A 407      10                                                       
HETNAM     DMS DIMETHYL SULFOXIDE                                               
HETNAM     IMD IMIDAZOLE                                                        
HETNAM     RQH (1~{S})-1-(4-CHLORANYLPHENOXY)-1-IMIDAZOL-1-YL-3,3-              
HETNAM   2 RQH  DIMETHYL-BUTAN-2-ONE                                            
HETSYN     RQH CLIMBAZOLE                                                       
FORMUL   2  DMS    5(C2 H6 O S)                                                 
FORMUL   3  IMD    C3 H5 N2 1+                                                  
FORMUL   4  RQH    C15 H17 CL N2 O2                                             
FORMUL   9  HOH   *392(H2 O)                                                    
SITE     1 AC1  8 GLN A  74  LEU A  75  ARG A  76  PHE A 223                    
SITE     2 AC1  8 THR A 224  ASP A 263  HOH A 556  HOH A 584                    
SITE     1 AC2  4 PRO A  96  GLN A 273  ASN A 274  HOH A 583                    
SITE     1 AC3 16 VAL A 104  ARG A 105  ASP A 176  GLU A 178                    
SITE     2 AC3 16 ASN A 228  LEU A 232  PRO A 241  HOH A 509                    
SITE     3 AC3 16 HOH A 512  HOH A 594  HOH A 598  HOH A 724                    
SITE     4 AC3 16 HOH A 739  HOH A 787  HOH A 841  HOH A 886                    
SITE     1 AC4  4 GLY A  15  MET A  17  LYS A  97  HOH A 600                    
SITE     1 AC5  2 TYR A 101  HOH A 659                                          
SITE     1 AC6  6 MET A   6  PHE A   8  SER A 123  GLN A 127                    
SITE     2 AC6  6 ARG A 298  HOH A 678                                          
SITE     1 AC7  6 PHE A 140  ASN A 142  HIS A 163  MET A 165                    
SITE     2 AC7  6 GLU A 166  HOH A 501                                          
CRYST1  112.504   52.829   44.663  90.00 102.80  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008889  0.000000  0.002020        0.00000                         
SCALE2      0.000000  0.018929  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.022961        0.00000                         
HETATM    1  C10 RQH A 403      30.177  -6.408   1.980  0.65 45.03           C
ANISOU    1  C10 RQH A 403     4771   5800   6537    452    761    571       C
HETATM    2  C15 RQH A 403      25.184  -7.174   3.971  0.65 47.71           C
ANISOU    2  C15 RQH A 403     5455   6098   6574    278    489    164       C
HETATM    3  C17 RQH A 403      23.302  -7.285   5.453  0.65 39.10           C
ANISOU    3  C17 RQH A 403     4438   5015   5405    201    355     64       C
HETATM    4  C01 RQH A 403      25.469  -2.592   3.962  0.65 52.57           C
ANISOU    4  C01 RQH A 403     5979   6819   7178    112    281    205       C
HETATM    5  C02 RQH A 403      26.837  -2.396   4.660  0.65 51.24           C
ANISOU    5  C02 RQH A 403     5700   6666   7103     98    242    321       C
HETATM    6  C03 RQH A 403      26.562  -2.016   6.112  0.65 53.54           C
ANISOU    6  C03 RQH A 403     5999   6961   7381     35    118    316       C
HETATM    7  C04 RQH A 403      27.527  -1.255   3.924  0.65 50.94           C
ANISOU    7  C04 RQH A 403     5614   6648   7094     78    243    376       C
HETATM    8  C05 RQH A 403      27.780  -3.635   4.576  0.65 50.69           C
ANISOU    8  C05 RQH A 403     5566   6585   7108    166    326    397       C
HETATM    9  C07 RQH A 403      27.289  -4.851   3.872  0.65 51.21           C
ANISOU    9  C07 RQH A 403     5702   6617   7139    236    435    339       C
HETATM   10  C09 RQH A 403      29.264  -6.438   3.026  0.65 44.59           C
ANISOU   10  C09 RQH A 403     4757   5747   6437    386    643    498       C
HETATM   11  C12 RQH A 403      28.932  -4.596   1.759  0.65 45.72           C
ANISOU   11  C12 RQH A 403     4933   5923   6515    333    628    457       C
HETATM   12  C14 RQH A 403      25.861  -6.407   4.952  0.65 50.78           C
ANISOU   12  C14 RQH A 403     5750   6524   7020    238    405    234       C
HETATM   13  C16 RQH A 403      23.884  -7.618   4.231  0.65 42.71           C
ANISOU   13  C16 RQH A 403     4906   5448   5872    253    455     78       C
HETATM   14  C18 RQH A 403      23.966  -6.540   6.397  0.65 44.27           C
ANISOU   14  C18 RQH A 403     5017   5700   6102    169    283    123       C
HETATM   15  C19 RQH A 403      25.246  -6.101   6.150  0.65 46.83           C
ANISOU   15  C19 RQH A 403     5260   6039   6496    182    300    208       C
HETATM   16  N08 RQH A 403      28.431  -5.290   2.890  0.65 48.21           N
ANISOU   16  N08 RQH A 403     5267   6228   6824    314    563    423       N
HETATM   17  N11 RQH A 403      29.963  -5.265   1.207  0.65 41.15           N
ANISOU   17  N11 RQH A 403     4301   5332   6003    416    749    545       N
HETATM   18  O06 RQH A 403      28.909  -3.622   5.009  0.65 47.65           O
ANISOU   18  O06 RQH A 403     5080   6215   6811    164    308    507       O
HETATM   19  O13 RQH A 403      27.127  -5.971   4.697  0.65 53.64           O
ANISOU   19  O13 RQH A 403     6017   6904   7458    254    429    334       O
HETATM   20 CL1  RQH A 403      21.708  -7.791   5.829  0.65 27.11          Cl
ANISOU   20 CL1  RQH A 403     3003   3483   3813    173    318    -21      Cl
HETATM   21  H10 RQH A 403      30.936  -7.154   1.793  0.65  0.00           H
HETATM   22  H15 RQH A 403      25.667  -7.413   3.035  0.65  0.00           H
HETATM   23  H07 RQH A 403      26.371  -4.637   3.326  0.65  0.00           H
HETATM   24  H09 RQH A 403      29.197  -7.190   3.798  0.65  0.00           H
HETATM   25  H12 RQH A 403      28.541  -3.659   1.391  0.65  0.00           H
HETATM   26  H16 RQH A 403      23.344  -8.205   3.503  0.65  0.00           H
HETATM   27  H18 RQH A 403      23.483  -6.300   7.332  0.65  0.00           H
HETATM   28  H19 RQH A 403      25.770  -5.518   6.892  0.65  0.00           H
HETATM   29 H011 RQH A 403      25.615  -2.638   2.882  0.65  0.00           H
HETATM   30 H012 RQH A 403      24.814  -1.756   4.204  0.65  0.00           H
HETATM   31 H013 RQH A 403      25.015  -3.522   4.306  0.65  0.00           H
HETATM   32 H031 RQH A 403      27.470  -1.612   6.561  0.65  0.00           H
HETATM   33 H032 RQH A 403      25.774  -1.264   6.148  0.65  0.00           H
HETATM   34 H033 RQH A 403      26.246  -2.901   6.665  0.65  0.00           H
HETATM   35 H041 RQH A 403      28.502  -1.069   4.374  0.65  0.00           H
HETATM   36 H042 RQH A 403      26.916  -0.355   3.995  0.65  0.00           H
HETATM   37 H043 RQH A 403      27.656  -1.525   2.876  0.65  0.00           H
CONECT    4    5   30   31   29
CONECT    5    4    6    7    8
CONECT    6    5   34   32   33
CONECT    7    5   37   35   36
CONECT    8    5    9   18
CONECT    9    8   16   19   23
CONECT   10    1   16   24
CONECT    1   10   17   21
CONECT   11   16   17   25
CONECT   12    2   15   19
CONECT    2   12   13   22
CONECT   13    2    3   26
CONECT    3   13   14   20
CONECT   14    3   15   27
CONECT   15   12   14   28
CONECT   20    3
CONECT   29    4
CONECT   30    4
CONECT   31    4
CONECT   32    6
CONECT   33    6
CONECT   34    6
CONECT   35    7
CONECT   36    7
CONECT   37    7
CONECT   23    9
CONECT   24   10
CONECT   21    1
CONECT   25   11
CONECT   22    2
CONECT   26   13
CONECT   27   14
CONECT   28   15
CONECT   16    9   10   11
CONECT   17    1   11
CONECT   18    8
CONECT   19    9   12
END
